Macleods Pharma Picks Banks for $1 Billion Mumbai IPO
- Drugmaker taps banks including Edelweiss, ICICI and JPMorgan
- Pharmaceutical firm to file draft prospectus by January
This article is for subscribers only.
Indian drugmaker Macleods Pharmaceuticals Ltd. has selected banks including Edelweiss Financial Services Ltd. and ICICI Securities Ltd. to manage its Mumbai initial public offering, according to people familiar with the matter.
The 35-year-old company has also picked JPMorgan Chase & Co. for the listing, the people said. More bankers could be added later, they said, asking not to be named as the information is private. Macleods could raise about $1 billion from the listing, one of the people said.